Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortSlows the digestion of starch to blunt post-meal sugar rises.First-choice tablet for type 2 diabetes.
Body systemDiabetes & WeightDiabetes & Weight
Drug classAlpha-glucosidase inhibitorsBiguanides
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesType 2 diabetes (add-on)Type 2 diabetes, Prediabetes (some countries), Gestational diabetes, Polycystic ovary syndrome (off-label)
How it worksSlows how quickly starch becomes sugar in the gut.Makes your liver release less sugar and helps your body respond to insulin.
Starts workingWith the first mouthfulBlood sugar improves over 1–2 weeks
Half-life2 hours (not significantly absorbed)About 6 hours
Typical adult dose25–50 mg at the start of each main meal, increasing to 100 mg three times a day.Start 500 mg once or twice a day with meals; increase gradually to 1.5–2 g a day (max 2.55–3 g).
FormsTabletTablet, Modified-release tablet, Oral solution, Combination tablets
Common side effectsWind, Bloating, Diarrhoea, Abdominal painDiarrhoea, Nausea, Stomach pain, Metallic taste, Loss of appetite
Serious side effectsRaised liver enzymes (high doses), Bowel obstruction (rare)Lactic acidosis (very rare, mainly with severe kidney failure or acute illness), Vitamin B12 deficiency with long-term use
Don't take ifInflammatory bowel disease; Bowel obstruction or hernia; Severe kidney impairment; CirrhosisSevere kidney impairment (eGFR below 30); Acute illness with dehydration, sepsis or shock; Before and after iodinated contrast scans in at-risk patients; Heavy alcohol use or liver disease
AlcoholBest to limit. Alcohol can alter blood sugar control.Best to limit. Heavy drinking raises the risk of lactic acidosis and low blood sugar.
PregnancyUsually avoidedNot recommended; insulin is the standard.Generally considered safeWidely used for gestational and type 2 diabetes in pregnancy.
BreastfeedingUsually avoidedNot recommended.Generally considered safeConsidered acceptable.
In use since—1957
Brand namesUnited States: PrecoseUnited Kingdom: GlucobayIndia: Glucobay, Acarbose (generic)United States: Glucophage, GlumetzaUnited Kingdom: Glucophage, Sukkarto SRIndia: Glycomet, Glyciphage, Obimet
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA10BF01A10BA02

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker